Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Roche launches new highly-sensitive test to more easily diagnose patients who…
The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity to assess the full spectrum of B-cell lymphoma subtypes. 1,2 The test helps differentiate a B-cell cancer from a normal, reactive immune response, providing diagnostic certainty for healthcare providers and their patients. B-cell lymphoma accounts for approximately 85 percent of non-Hodgkin lymphoma (NHL) cases, which is the tenth...
Nasdaq GlobeNewswire
20/06/2024
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development…
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines is expanding its pharmaceutical development capabilities.Behind SynQube GmbH are the two pioneers of cannabis medicine and founders of THC Pharm GmbH, Christian Steup and Holger Rönitz, with more than 25 years of experience with cannabinoids and psychotropic substances.Together, Avextra and SynQube share a wealth of experience and are ideally positioned to pursue joint drug...
Nasdaq GlobeNewswire
20/06/2024
Prediabetes Market is Projected to Boost at a Moderate Growth Rate by 2034…
Key Takeaways from the Prediabetes Market Report Key Takeaways from the Prediabetes Market Report Discover which therapies are expected to grab the major prediabetes market share @Prediabetes Market Report Prediabetes Overview Prediabetes is a condition characterized by blood sugar levels that are higher than normal but not yet high enough to be diagnosed as type 2 diabetes. It serves as a critical warning sign and a window of opportunity for individuals to take steps to...
PR Newswire
19/06/2024
Bioretec reports successful clinical outcomes from U.S. controlled launch of…
Further enquiries Further enquiries Alan Donze, CEO, tel. +358 40 663 5011 Johanna Salko, CFO, tel. +358 40 754 8172 Bioretec in brief Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and...
PR Newswire
19/06/2024
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
Updating the audience for its flagship novel immunotherapy, pelareorep, Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) presented two abstracts demonstrating further potential for the intravenously delivered immunotherapeutic agent in pancreatic cancer and its immunotherapeutic mechanism of action across multiple cancer indications. Updating the audience for its flagship novel immunotherapy, pelareorep,Oncolytics Biotech Inc.(NASDAQ: ONCY) (TSX: ONC)presented two abstracts...
PR Newswire
19/06/2024
OSE Immunotherapeutics Reports on its 2024 General Shareholders' Meeting and the…
OSE Immunotherapeutics Reports on its2024 General Shareholders' Meeting and the Evolution of the Board of Directors Ready to Drive the Strategic Company's GrowthNantes, France – June 19, 2024, 6:15pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)today announced that all the resolutions submitted to a vote at the Combined General Shareholders' Meeting were approved as proposed by OSE Immunotherapeutics' Board of Directors.Shareholders also approved...
Nasdaq GlobeNewswire
19/06/2024
High-Quality Kitchen Appliances and Utensils Converge at the 135th Canton Fair…
Realwin Metal Manufacture Co., Ltd. is presenting its flagship new product, the 7-piece Stainless Steel Cookware Set on the platform. This set is crafted from high-quality stainless steel and composite bottom which not only offers exceptional strength and durability, but also ensures rapid heating and maintains optimal cooking temperature for prolonged periods. As for design, the product incorporates unique contoured edges and precision interior finishing processes to prevent splashing and…
PR Newswire
19/06/2024
Trenbolone Enanthate Industry to hit 91.5 million dollars by 2031: Coherent…
Market Dynamics: Market Dynamics : The global Trenbolone Enanthate market is primarily driven by rising demand for anabolic steroids from bodybuilders and athletes across the globe. Trenbolone enanthate is one of the most commonly used anabolic steroids for bulking and cutting cycles due to its high anabolic and low androgenic properties. It promotes significant gains in muscle mass and strength within short span without much emphasis on water retention. Additionally, increasing awareness...
PR Newswire
19/06/2024
Genotyping Assay Market Surges to USD 37.1 Billion by 2029: Thermo Fisher and…
Browse in-depth TOC on "Genotyping Assay Market" Browse in-depth TOC on "Genotyping Assay Market" 444 - Tables 59 - Figures 388 - Pages TheMay 2024edition of the genotyping assay market report introduces significant enhancements and updates to provide a comprehensive view of the market: These enhancements in theMay 2024edition aim to deliver deeper insights and a more comprehensive understanding of the genotyping assay market, aiding stakeholders in strategic...
PR Newswire
19/06/2024
Flame Resistant and Retardant Fabric Market is Anticipated to reach US$ 13.39…
Flame-resistant and retardant fabrics are engineered to self-extinguish or resist the spread of flames by minimizing the risk of devastating fires and potential loss of life. Demand growth for these fabrics is being led by stringent fire safety regulations and heightened awareness of workplace hazards, especially in critical sectors such as oil & gas exploration, mining, and manufacturing. Flame-resistant and retardant fabrics are engineered to self-extinguish or resist the spread of flames…
PR Newswire
19/06/2024
Home Medical Equipment Market to be Worth $62.89 Billion by 2030 - Exclusive…
Home medical equipment is used to fulfill patients' healthcare needs at home. It is mostly used when a patient or individual requires prolonged care or stays in healthcare facilities. Home medical equipment includes therapeutic, mobility, assistive, and patient support equipment used by individuals or patients to control numerous conditions, such as respiratory diseases, mobility disorders, and cancer. Home medical equipment is used to fulfill patients' healthcare needs at home. It is mostly...
PR Newswire
19/06/2024
Philips completes cancellation of 4.4 million shares
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021.Philips' current issued share capital amounts to EUR 187,987,876.80 representing 939,939,384 common shares.More information is available here . For further...
Nasdaq GlobeNewswire
19/06/2024
BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)
The annual general meeting resolved to adopt the profit and loss account and balance sheet and the consolidated profit and loss statement and consolidated balance sheet. The annual general meeting also resolved to allocate the company's result in accordance with the board's proposal, which means that no dividend will be paid, and that available funds of SEK 60,668,202 will be carried forward. The annual general meeting resolved to adopt the profit and loss account and balance sheet and the...
PR Newswire
19/06/2024
Daewoong Presents Enavogliflozin's Phase 3 Pooled Analysis Results at 84th ADA…
The study shows Enavogliflozin's superior blood glucose-lowering effects compared to dapagliflozin, with a significant reduction in glycated hemoglobin (HbA1c) levels. Over 24 weeks, Enavogliflozin reduced HbA1c by 0.94%, compared to 0.77% with dapagliflozin. Additional benefits include reduced fasting plasma glucose levels, increased urinary glucose excretion, and improved insulin resistance. The study shows Enavogliflozin's superior blood glucose-lowering effects compared to dapagliflozin,...
PR Newswire
19/06/2024
Smartee Presents Two Decades of Progress at the 99th EOS Congress in Athens
Smartee's booth at the EOS Congress drew significant attention from orthodontists eager to explore the company's two decades of achievement. Highlights included: Smartee's booth at the EOS Congress drew significant attention from orthodontists eager to explore the company's two decades of achievement. Highlights included: As part of its participation at EOS, Smartee hosted an educational workshop led by Dr. Tao Guo, which provided attendees with valuable insights into Smartee GS Mandibular...
PR Newswire
19/06/2024
Gareth Williams appointed CEO of Bionical Health
Bionical Health is the rebranded Health Outcomes (Clinical) division of Bionical Solutions. In May, Bionical Solutions decided to demerge two of its business divisions, Multi-Channel Engagement (Commercial) and Health Outcomes (Clinical), into separate legal and operating entities within the parent company to afford each business greater autonomy to focus on its specific growth requirements and better meet the needs of clients. The demerger will complete on 1 August 2024. Bionical Health is…
PR Newswire
19/06/2024
Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New…
Major pharmaceutical companies are eager to partner with or acquire ADC developers to enhance their oncology pipelines. ADCs combine a cytotoxic payload, a monoclonal antibody (mAb), and a chemical linker, offering greater target specificity and a wider therapeutic index than traditional therapies, delivering toxic agents directly to cancer cells while sparing healthy tissues. Major pharmaceutical companies are eager to partner with or acquire ADC developers to enhance their oncology…
PR Newswire
19/06/2024
Implantica announces further expansion of RefluxStop™ access in the UK NHS…
He says: "The patient is doing well following surgery; she recovered quickly and was eating normally within days. Her severe symptoms, including vomiting, chest pain, sore throat, reflux, and epigastric pain and discomfort, have all been resolved without the need for ongoing medication." He says: "The patient is doing well following surgery; she recovered quickly and was eating normally within days. Her severe symptoms, including vomiting, chest pain, sore throat, reflux, and…
PR Newswire
19/06/2024
European Commission grants Sobi® Marketing Authorisation for ALTUVOCT™ for…
"Despite advancements, haemophilia still limits the possibilities of patients' lives and this means there is still a need for treatments that offer elevated protection. ALTUVOCT's high-sustained factor VIII activity and once-weekly dosing schedule have the potential to significantly improve quality of life for people with haemophilia A. The trials demonstrated substantial improvements in the prevention and treatment of bleeds along with significant improvements in physical health, pain, and…
PR Newswire
19/06/2024
DNA Health & Wellness, the MENA Regions' Largest Health Optimisation and…
"We are excited to bring our innovative approach to health and wellness toAbu Dhabi. Our success inDubaihas demonstrated that there is a strong demand for personalised and preventative healthcare; our expansion reflects our commitment and mission to making advanced health solutions more accessible to a wider community."DrNasr Al Jafari, Co-Founder & Chief Medical Officer of DNA Health & Wellness Group. Located inCentral Abu Dhabi, the expansion marks a...
PR Newswire
19/06/2024
ZA Tech Rebrands as Peak3, Raises US$35M Series A led by EQT
Besides the successful fundraising, Peak3 has recently achieved key milestones underpinning the rebranding. These transformative achievements include launching its first multi-country, multi-tenant core modernisation in Europe, rolling out an integrated customer data and big data platform for scaling analytics and AI capabilities, and establishing its first technology centre in Europe. The rebranding coincides with another major milestone: Issuing over a billion insurance policies on Peak3's…
PR Newswire
19/06/2024
Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL…
CLTI and CLI are debilitating conditions that affect the blood vessels in the legs and feet. Those afflicted with this disease often suffer from severe pain, numbness, and open non-healing wounds. Without intervention, these conditions can lead to amputation, loss of mobility, and death. Micro Medical Solutions is committed to providing a potential solution for this medically complex and underserved patient population. CLTI and CLI are debilitating conditions that affect the blood vessels in...
PR Newswire
19/06/2024
Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key…
Key Takeaways from the Obesity Market Report Key Takeaways from the Obesity Market Report Discover which therapies are expected to grab major obesity market share @Obesity Market Report Obesity Overview Obesity is acknowledged as a chronic condition or noncommunicable ailment, characterized by a complex, multifaceted set of factors. It predominantly involves excessive body fat, along with being overweight, which can have metabolic implications beyond just physical size...
PR Newswire
18/06/2024
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Company Announcement COPENHAGEN, Denmark; June 18, 2024 –Genmab A/S(Nasdaq: GMAB) will increase its share capital by 6,986 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:424 shares at DKK 1,025.00, 2,305 shares at DKK 1,032.00, 1,058 shares at DKK 1,161.00, 562 shares at...
Nasdaq GlobeNewswire
18/06/2024
Altri Comunicati
